GlassScriptPhysician profile
Alicia Land
NPI 1922461995
$5,341.37
in general payments reported to CMS, 2019-2025
51 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 92% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.93 · 2022: $754 · 2023: $1,264 · 2024: $1,494 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,392 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,392.48 |
| Education | $116.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $547.79 | 2022-2025 | |
| Lilly USA, LLC | $386.39 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Merck Sharp & Dohme LLC | $363.49 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Regeneron Healthcare Solutions, INC. | $342.19 | 2022-2025 | Libtayo, Lynozyfic |
| Daiichi Sankyo INC. | $318.82 | 2022-2025 | Enhertu, Injectafer |
| Eisai INC. | $306.68 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $256.44 | 2022-2025 | Calquence, Imfinzi, Enhertu |
| Pharmaessentia USA Corporation | $214.02 | 2023-2025 | Besremi |
| Tersera Therapeutics LLC | $175.26 | 2023-2025 | Zoladex, Quzyttir |
| Takeda Pharmaceuticals U.S.A., INC. | $160.18 | 2022-2024 | Alunbrig, Iclusig, Ninlaro |
| E.R. Squibb & Sons, L.L.C. | $159.76 | 2022-2025 | Opdivo |
| Stemline Therapeutics INC. | $151.27 | 2023-2025 | Orserdu |
| Janssen Biotech, INC. | $149.84 | 2023-2025 | Talvey, Darzalex, Tecvayli |
| Deciphera Pharmaceuticals INC. | $148.55 | 2022-2025 | Qinlock, Romvimza |
| Celgene Corporation | $143.81 | 2024-2025 | Reblozyl |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $143.06 | 2023-2025 | Onivyde, Somatuline Depot |
| Genentech USA, INC. | $140.12 | 2023-2025 | Polivy, Tecentriq, Columvi |
| Exelixis INC. | $114.70 | 2022-2025 | Cabometyx |
| Glaxosmithkline, LLC. | $101.66 | 2023-2024 | Jemperli, Ojjaara |
| Incyte Corporation | $99.25 | 2022-2025 | Jakafi, Zynyz, Monjuvi |
| Blueprint Medicines Corporation | $69.20 | 2022-2024 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $53.42 | 2023 | |
| Adc Therapeutics America, INC. | $51.34 | 2021-2024 | |
| Astellas Pharma US INC | $48.20 | 2024 | Padcev, Xospata |
| Pharmacosmos Therapeutics INC. | $43.44 | 2025 | Monoferric |
| Seagen INC. | $43.00 | 2022-2023 | Adcetris, Tukysa |
| Aveo Pharmaceuticals, INC. | $41.39 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $36.12 | 2024-2025 | Sancuso |
| Pfizer INC. | $34.62 | 2023-2025 | |
| Genmab U.S., INC. | $34.26 | 2025 | Epkinly |
| Array Biopharma INC | $33.36 | 2022-2023 | Mektovi, Lorbrena, Braftovi |
| Veracyte, INC. | $32.97 | 2023 | |
| Abbvie INC. | $32.89 | 2025 | |
| Apellis Pharmaceuticals, INC. | $32.46 | 2023 | Empaveli |
| Beigene USA, INC. | $29.18 | 2024 | Brukinsa |
| Servier Pharmaceuticals LLC | $28.47 | 2024 | |
| Spectrum Pharmaceuticals INC. | $25.77 | 2023 | Rolvedon |
| Novocure INC. | $24.11 | 2025 | Optune Lua (Novottf-200t) |
| Sobi, INC | $22.50 | 2023 | |
| Acrotech Biopharma INC. | $22.41 | 2021 | |
| Syndax Pharmaceuticals, INC. | $21.06 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.76 | 2021 | |
| Sumitomo Pharma America, INC. | $18.95 | 2023 | Orgovyx |
| Caris Mpi, INC. | $17.76 | 2025 | Mi Cancer Seek |
| Rigel Pharmaceuticals, INC. | $14.97 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Azurity Pharmaceuticals, INC. | $14.87 | 2024 | Vivimusta |
| Karl Storz Endoscopy-America | $14.70 | 2025 | Na |
| Agios Pharmaceuticals, INC. | $14.68 | 2024 | Pyrukynd |
| Morphosys, US INC. | $14.19 | 2022 | |
| Beone Medicines USA, INC. | $14.15 | 2025 | Tevimbra |
| Emd Serono, INC. | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Land listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.